688016 fundamentals
An in-depth look to SHANGHAI MICROPORT ENDOVASCULAR MEDTEC（GROUP） operating, investing, and financing activities
688016 free cash flow for Q1 24 is 174.57 M CNY. For 2023, 688016 free cash flow was 380.96 M CNY and operating cash flow was 571.22 M CNY.
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
0.00
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: CNY
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
TTM